Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Oncorus. Among the most successful fund investment fields, there are Biotechnology, Medical.
The typical case for the fund is to invest in rounds with 7 participants. The meaningful sponsors for the fund in investment in the same round are MPM Capital, Long March Investment Fund, Excelyrate Capital. In the next rounds fund is usually obtained by UTC Investment Co., UBS Oncology Impact Fund, Surveyor Capital.
The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2016.
| Fund Name | Location |
| Bargal R&D Investment | - |
| Ganyuan Lianhe | Beijing, China, Haidian |
| HKJ Group | Beijing, Beijing Shi, China |
| KOGEI | Japan, Tokyo |
| Lazard Korea | Seoul, Seoul-t'ukpyolsi, South Korea |
| New Stack Ventures | Chicago, Illinois, United States |
| Rihe Keji | Beijing, China, Haidian |
| Round Hill Ventures | England, London, United Kingdom |
| ShapeShift | Colorado, Denver, United States |
| Wuxi Kaite Touzi | China, Jiangsu, Wuxi Shi |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Oncorus | $57M | 19 Jul 2016 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Oncorus | $57M | 19 Jul 2016 | Cambridge, Massachusetts, United States |
